Cargando…
Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
Autores principales: | Nagarkar, Rajnish, Patil, Darshana, Limaye, Sewanti, Devhare, Pradip, Ghaisas, Ashwini, Srivastava, Navin, Apurwa, Sachin, Patil, Sanket, John, Jinumary, Raazi, Zarrine, Shreenivas, Aditya, Sambath, Janani, Srinivasan, Ajay, Kumar, Prashant, Akolkar, Dadasaheb, Datar, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629807/ https://www.ncbi.nlm.nih.gov/pubmed/36342460 http://dx.doi.org/10.18632/oncotarget.28296 |
Ejemplares similares
-
Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
por: Nagarkar, Rajnish, et al.
Publicado: (2020) -
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
por: Limaye, Sewanti, et al.
Publicado: (2022) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
por: Limaye, Sewanti, et al.
Publicado: (2021) -
A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
por: Limaye, Sewanti, et al.
Publicado: (2020) -
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
por: Patil, Darshana, et al.
Publicado: (2022)